CDSCO Panel Approves Novartis Protocol Amendment Proposal To Study Ruxolitinib and Panobinostat Dr. Divya Colin30 Jun 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Wockhardt plans to launch antibiotic Zaynich in early FY26 Ruchika Sharma30 Jun 2024 2:00 PM ISTMumbai: Wockhardt said that research and trials for the antibiotic Zaynich are advancing well, with plans for an early launch in FY26. Habil...
AstraZeneca Imfinzi fails in late-stage trial to treat type of lung cancer Ruchika Sharma30 Jun 2024 11:30 AM ISTCambridge: AstraZeneca has announced the high-level results from the ADJUVANT BR.31 Phase III trial, sponsored by the Canadian Cancer Trials...
Emcure Pharma set to launch IPO on July 3 Ruchika Sharma30 Jun 2024 10:15 AM ISTEmcure Pharmaceuticals, backed by Bain Capital, is set to float its Initial Public Offering (IPO) on July 3. The initial share sale will run until...
CDSCO Panel Approves Roche's Protocol Amendment Proposal To Study Inavolisib in combination with Phesgo Dr. Divya Colin29 Jun 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Aurobindo Pharma arm buys Ace Lab for Rs 17.91 crore Ruchika Sharma29 Jun 2024 3:13 PM ISTHyderabad: Aurobindo Pharma has informed in a BSE filing that Agile Pharma BV, The Netherlands, a wholly owned step-down subsidiary of the...
Over 36 percent of inspected drug-making units had to be shut: CDSCO chief Ruchika Sharma29 Jun 2024 2:30 PM IST"The issues in the Indian pharma industry relate to "non-compliance which leads to quality issues," CDSCO Chief
Boosting local manufacturing: India plans incentives for diabetes, obesity drug makers in 2026 Ruchika Sharma29 Jun 2024 12:57 PM ISTBengaluru: India is set to provide incentives aimed at boosting domestic production of GLP-1 drugs, which are utilized to manage diabetes and...
Roche Vabysmo gets CHMP recommendation for third indication retinal vein occlusion Ruchika Sharma29 Jun 2024 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Alembic Pharma secures USFDA okay for Doxycycline Capsules for inflammatory lesions of rosacea Ruchika Sharma28 Jun 2024 5:41 PM ISTAlembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for...
CDSCO Panel Approves Novartis Protocol Amendment Proposal To Study Ianalumab Dr. Divya Colin28 Jun 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Jubilant Ingrevia receives USFDA EIR for Baruch facility Ruchika Sharma28 Jun 2024 12:30 PM ISTNoida: Jubilant Ingrevia Limited has announced successful outcome of the USFDA inspection with the receipt of Establishment Inspection report...
